Cell Line Development & Engineering Stream

Discover how artificial intelligence, predictive modelling, and big-data analytics are transforming the way cell lines are designed, screened, and optimised. Learn how leading innovators are using digital tools to predict productivity, enhance quality, and accelerate decision-making across bioprocess development.

Designing next-gen hosts and vectors is critical for producing complex multi-specific biologics efficiently. Dive into the latest advances in host cell platforms, gene editing, and expression vector optimisation that enable consistent, high-performing cell lines for complex biologics and bispecifics. Sessions will reveal how next-generation engineering strategies are delivering higher yields, improved stability, and greater flexibility for emerging therapeutic formats.

Hear how leading organisations are overcoming traditional bottlenecks to compress cell line development timelines and ensure smooth, reliable scale-up to GMP manufacturing. Focusing on early integration between CLD and process development, risk mitigation, and platform approaches that bring therapies to patients faster.

High-throughput and automated screening is revolutionizing clone selection, enabling faster, more reproducible results and improving decision-making in early-stage CLD. Learn how integrated digital workflows and automated analytics are increasing reproducibility, speed, and productivity across the cell line development pipeline.